• Rebl, Henrike
• Haag, Antonia
• Renner, Jürgen
• Wienecke, Marion
• Cruz, Julia E. De La
• Kram, Wolfgang
• Springer, Armin
• Epting, Thomas
• Hakenberg, Oliver W.
• Soria, Federico

Abstract

<jats:p>The insertion of a ureteral stent provides acute care by restoring urine flow and alleviating urinary retention or dysfunction. The problems of encrustation, bacterial colonization and biofilm formation become increasingly important when ureteral stents are left in place for a longer period of time. One way to reduce encrustation and bacterial adherence is to modify the stent surface with a diamond-like carbon coating, in combination with copper doping. The biocompatibilities of the Elastollan® base material and the a-C:H/Cu-mulitilayer coating were tested in synthetic urine. The copper content in bladder tissue was determined by atomic absorption spectroscopy and in blood and in urine by inductively coupled plasma mass spectrometry. Encrustations on the materials were analyzed by scanning electron microscopy, energy dispersive X-ray spectroscopy and Fourier transform infrared spectroscopy. A therapeutic window for copper ions of 0.5–1.0 mM was determined to kill bacteria without affecting human urothelial cells. In the rat animal model, it was found that copper release did not reach toxic concentrations in the affecting tissue of the urinary tract or in the blood. The encrustation behavior of the surfaces showed that the roughness of the amorphous carbon layer with the copper doping is probably the causal factor for the higher encrustation.</jats:p>

Topics

• impedance spectroscopy
• surface
• amorphous
• Carbon
• scanning electron microscopy
• copper
• Fourier transform infrared spectroscopy
• spectrometry
• X-ray spectroscopy
• inductively coupled plasma mass spectrometry